The short version
- Why people research itCollagen, skin remodeling, wound healing and hair support.
- What the evidence isThere are no human trials of injected GHK-Cu for any systemic endpoint.
- What to watchMetallic taste, nausea or stomach pain.
How GHK-Cu works
Copper-binding remodeling peptide — stimulates collagen/elastin, wound repair, hair follicles and antioxidant defense.
The molecule is three residues — Gly-His-Lys — and everything that matters about it is the histidine. The copper(II) ion is held by a three-nitrogen donor set: the free N-terminal amine of glycine, the deprotonated nitrogen of the first peptide bond, and the imidazole nitrogen of the histidine side chain.
The step nobody explains is how the copper gets out, and it was measured directly. Ufnalska 2021 followed the reduction of Cu(II)-GHK by glutathione and found it proceeds through intermediate Cu(II)-thiolate species; the paper's own description of the complex is a handy chelate for biological Cu(II) reduction. Glutathione sits at millimolar concentration inside cells and micromolar outside.
- Injectable
- Oral
- Topical
On the goal map: Collagen synthesis & dermal matrix (Skin, hair & aesthetics)
Research on GHK-Cu6 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
The topical human evidence is real and it is the best-supported claim on this page. Controlled trials of copper-peptide creams show measurable improvements in skin density, fine lines and wound healing — which is why GHK-Cu is a mainstream cosmetic ingredient rather than a research chemical.
There are no human trials of injected GHK-Cu for any systemic endpoint.
No completed human trial
Correlative data
Plasma GHK-Cu falls sharply with age — roughly 200 ng/mL at 20 down to about 80 by 60 — which is an observation about human biology rather than about supplementation, and it is the origin of the whole systemic-use idea.
Injected use is reported for hair, skin and connective tissue. It reliably causes a local reaction at the injection site, which is the most consistent thing in the anecdotal record.
How the mechanism reads
A copper-carrying tripeptide that modulates gene expression broadly — published transcriptomic work shows it shifts expression of a very large number of genes toward a repair-associated pattern.
MechanisticThe copper is the mechanism and also the limit. It works by delivering copper into cells, and more signaling is not straightforwardly better.
Mechanistic
Sources
- Ufnalska I, et al. Intermediate Cu(II)-Thiolate Species in the Reduction of Cu(II)GHK by Glutathione: A Handy Chelate for Biological Cu(II) Reduction. Inorganic Chemistry 2021 · PMID 34781677
- Deng M, et al. Glycyl-L-histidyl-L-lysine-Cu2+ rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway. Journal of Cachexia, Sarcopenia and Muscle 2023 · PMID 36905132
- Pickart L, et al. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxidative Medicine and Cellular Longevity 2012 · PMID 22666519
GHK-Cu safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Wilson's disease or any copper-metabolism disorder.
- Active cancer, since the peptide raises growth factors and angiogenic signaling.
- Copper allergy.
- Large-area, high-strength use or injection if you already take copper or zinc supplements.
- Pregnancy, given limited data on added copper and growth signaling.
What’s expected
- Local skin and hair effects: collagen and elastin signaling, more follicle activity.
- Mild tingling or redness topically.
- Copper exposure that accumulates silently if used systemically.
Watch for
- Metallic taste, nausea or stomach pain.
- A mole or growth that changes.
- Spreading rash at a treated site.
Labs that tell you it’s working
- Copper, Serum: copper is about a sixth of this molecule's weight, so systemic use shows here.
- Ceruloplasmin: the carrier protein that tracks copper status.
- Zinc, Plasma: copper loading displaces zinc absorption.
- Complete Blood Count: both low and high copper can show as blood-count changes.
Copper(II)-binding tripeptide (Gly-His-Lys) remodeling skin, collagen and follicles; the copper is both the active ingredient and the constraint. PMID 22666519 PMID 36905132
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
GHK-Cu FAQ4 common questions
- Is GHK-Cu approved for human use?
- No. GHK-Cu is a research compound. No completed randomized human trial has given it yet.
- What is GHK-Cu researched for?
- Collagen, skin remodeling, wound healing and hair support.
- Which labs show whether it's doing anything?
- Copper, Serum; Ceruloplasmin; Zinc, Plasma; Complete Blood Count: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for GHK-Cu: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.





